Skip to main content

6 Results for “viabil”

Gore Launches Anti-Migration Assurance Program for GORE® VIABIL® Short Wire Biliary Endoprosthesis

Device is proven to reduce the risk of reintervention for patients with pancreatic and other cancers that obstruct the bile duct; replacement program can help limit overall costs of palliative care

GORE® VIABIL® Biliary Endoprosthesis Yedavalli Case Study: mitigation of stent migration concerns

GORE® VIABIL® Biliary Endoprosthesis case study – one of two from Dr. Yedavalli in 2023. It presents a successful resolution of high grade distal malignant biliary obstruction of the common bile duct.

PDF, 1 MB

GORE® VIABIL® Biliary Endoprosthesis Yedavalli Case Study: decreased resistance to bile flow

GORE® VIABIL® Biliary Endoprosthesis case study – one of two from Dr. Yedavalli in 2023. It presents a successful resolution of malignant biliary obstruction of the common bile duct with normalization of serum bilirubin and decreased pain.

PDF, 1 MB

PERC_GORE® VIABIL® Biliary Endoprosthesis - Brochure for Percutaneous Delivery, NA

North-American version. VIABIL Brochure for percutaneous delivery. New migration data demonstrates once again VIABIL's low migration rates.

PDF, 3.16 MB

PERC_GORE® VIABIL® Biliary Endoprosthesis - Sizing and Steps for Percutaneous deployment

Sizing table and step-by-step percutaneous deployment guide for Viabil

PDF, 384.25 KB

ENDO_GORE® VIABIL® Biliary Endoprosthesis Remains Patent at 266 Days

Case study - ePTFE/FEP covered stent-graft VIABIL® provided long-term palliation for jaundice caused by malignant obstruction of the common bile duct.

PDF, 534.26 KB